COVID-19 axSpA Study first results

SAA the Spondylitis Association of America and any-3 are carrying out a COVID 19 in Axial Spondyloarthritis survey in collaboration with ASIF.  SAA has worked closely with members of their Medical and Scientific Advisory Board and is spearheading research into the possible impact axial spondyloarthritis, and medications used for axial spondyloarthritis, may have on COVID-19.

We are still collecting responses, to find out how you can take part, click here.

Here you can find links to view the SAA’s reports on the survey findings so far:

The Effect of the HLA-B27 Gene on COVID-19

SAA’s COVID-19 and Spondyloarthritis Survey: Initial Findings Now Published!

Watch this space for further reports from ASIF and other global members taking part in the survey.






Other NEWS

ASIF’s new members

In the last few months the Trustees have approved applications from 3 different countries

Read More